Neoadjuvant Immunotherapy Improves Treatment for Early Resectable Non-Small-Cell Lung Cancer: A Systematic Review and Meta-analysis

OBJECTIVE: Immunotherapy has shown better efficacy and less toxicity than chemotherapy in the treatment of non-small-cell lung cancer (NSCLC) at advanced stage. This study evaluates the safety and efficacy of neoadjuvant immunotherapy for resectable NSCLC. METHODS: Literature examination was perform...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Peng, Yan, Yu, Yang, Liyuan, Wu, Danzhu, Wang, Hui, Lv, Yajuan, Zhang, Jiandong, Yu, Xinshuang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546650/
https://www.ncbi.nlm.nih.gov/pubmed/36213828
http://dx.doi.org/10.1155/2022/2085267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546650/
https://www.ncbi.nlm.nih.gov/pubmed/36213828
http://dx.doi.org/10.1155/2022/2085267

Ejemplares similares